Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control I Barbieri, K Tzelepis, L Pandolfini, J Shi, G Millán-Zambrano, SC Robson, ... Nature 552 (7683), 126-131, 2017 | 987 | 2017 |
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia E Yankova, W Blackaby, M Albertella, J Rak, E De Braekeleer, ... Nature 593 (7860), 597-601, 2021 | 838 | 2021 |
A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia K Tzelepis, H Koike-Yusa, E De Braekeleer, Y Li, E Metzakopian, ... Cell reports 17 (4), 1193-1205, 2016 | 698 | 2016 |
RNA modifications detection by comparative Nanopore direct RNA sequencing A Leger, PP Amaral, L Pandolfini, C Capitanchik, F Capraro, V Miano, ... Nature communications 12 (1), 7198, 2021 | 332 | 2021 |
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation EA Orellana, Q Liu, E Yankova, M Pirouz, E De Braekeleer, W Zhang, ... Molecular cell 81 (16), 3323-3338. e14, 2021 | 225 | 2021 |
Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition P Gallipoli, G Giotopoulos, K Tzelepis, ASH Costa, S Vohra, ... Blood, The Journal of the American Society of Hematology 131 (15), 1639-1653, 2018 | 163 | 2018 |
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs M Gozdecka, E Meduri, M Mazan, K Tzelepis, M Dudek, AJ Knights, ... Nature genetics 50 (6), 883-894, 2018 | 152 | 2018 |
Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts A Mupo, M Seiler, V Sathiaseelan, A Pance, Y Yang, AA Agrawal, F Iorio, ... Leukemia 31 (3), 720-727, 2017 | 145 | 2017 |
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia OM Dovey, JL Cooper, A Mupo, CS Grove, C Lynn, N Conte, RM Andrews, ... Blood, The Journal of the American Society of Hematology 130 (17), 1911-1922, 2017 | 79 | 2017 |
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4 K Tzelepis, E De Braekeleer, D Aspris, I Barbieri, MS Vijayabaskar, ... Nature communications 9 (1), 5378, 2018 | 72 | 2018 |
Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality R Szmyd, J Niska-Blakie, MK Diril, P Renck Nunes, K Tzelepis, A Lacroix, ... Oncogene 38 (7), 998-1018, 2019 | 65 | 2019 |
meCLICK-Seq, a substrate-hijacking and RNA degradation strategy for the study of RNA methylation S Mikutis, M Gu, E Sendinc, ME Hazemi, H Kiely-Collins, D Aspris, ... ACS central science 6 (12), 2196-2208, 2020 | 48 | 2020 |
Enhancing the genome editing toolbox: genome wide CRISPR arrayed libraries E Metzakopian, A Strong, V Iyer, A Hodgkins, K Tzelepis, L Antunes, ... Scientific reports 7 (1), 2244, 2017 | 48 | 2017 |
Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies N Han, W Hwang, K Tzelepis, P Schmerer, E Yankova, M MacMahon, ... Science Advances 7 (27), eabh3032, 2021 | 45 | 2021 |
Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype E Mylona, K Tzelepis, I Theohari, I Giannopoulou, C Papadimitriou, ... Histopathology 62 (3), 472-480, 2013 | 41 | 2013 |
KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements YZ Au, M Gu, E De Braekeleer, M Gozdecka, D Aspris, Y Tarumoto, ... Leukemia 35 (4), 1012-1022, 2021 | 35 | 2021 |
Proximity-induced nucleic acid degrader (PINAD) approach to targeted RNA degradation using small molecules S Mikutis, M Rebelo, E Yankova, M Gu, C Tang, AR Coelho, M Yang, ... ACS Central Science 9 (5), 892-904, 2023 | 33 | 2023 |
RNA-modifying enzymes and their function in a chromatin context K Tzelepis, O Rausch, T Kouzarides Nature structural & molecular biology 26 (10), 858-862, 2019 | 29 | 2019 |
Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomas E Mylona, S Melissaris, A Nomikos, I Theohari, I Giannopoulou, ... Pathology-Research and Practice 210 (8), 533-540, 2014 | 23 | 2014 |
Methylation of histone H3 at lysine 37 by Set1 and Set2 prevents spurious DNA replication H Santos-Rosa, G Millan-Zambrano, N Han, T Leonardi, M Klimontova, ... Molecular cell 81 (13), 2793-2807. e8, 2021 | 20 | 2021 |